Rare diseases
Investigational molecules
Locations
Back to Portugal673 clinical trials in Almada, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
PortugalStudy of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)
PortugalStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
PortugalStudy of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease
PortugalStudy on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes
PortugalStudy on the Effects of Semaglutide in Patients with Early Alzheimer's Disease
PortugalStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
PortugalStudy on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
PortugalStudy on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment
PortugalStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PortugalStudy on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis
PortugalStudy on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
PortugalThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary arterial hypertension and chronic obstructive pulmonary disease, evaluating novel treatments including ralinepag and itepekimab for long-term management of these conditions.
Research investigating treatments for systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, with studies on medications like upadacitinib and remibrutinib.
Studies examining treatments for multiple sclerosis, migraine prevention, and neurological conditions, testing medications such as ocrelizumab and atogepant.
Investigations into hypertrophic cardiomyopathy and stroke prevention, studying treatments like mavacamten and asundexian for improved cardiac outcomes.
Advanced studies in lung cancer, colorectal cancer, and head and neck cancers, evaluating novel immunotherapy combinations and targeted treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
